This image shows pancreatic cancer cells (nuclei in blue) growing as a sphere encased in membranes (red).

FREDERICK, Md. -- In early experiments, a targeted nanomedicine has safely halted the growth of pancreatic cancer — the deadliest of solid tumors — and prevented its most dangerous feature, metastasis, the spread of tumor cells.

Sarah Skoczen, research associate, pharmacology and toxicology, Nanotechnology Characterization Laboratory, prepares a mass spectrometer for sample analysis. 

FREDERICK, Md. -- Drug developers now have access to a shared analytical technology, developed and provided by the Frederick National Laboratory for Cancer Research, that helps fine-tune nanomedicine formulations and overcomes a key hurdle on the path toward Food and Drug Administration approval of effective new therapies and generic versions of nanomedicines. 

Pages